Interleukin-1 and interleukin-6 activities are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T-cell activation markers.
about
Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosusIntrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagementInflammatory cytokines in systemic lupus erythematosusPathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus ErythematosusLupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosusBANK1 controls CpG-induced IL-6 secretion via a p38 and MNK1/2/eIF4E translation initiation pathwayCytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus.Cytokine networks in systemic lupus erythematosusCytokines and systemic lupus erythematosusSerum S100B levels in patients with lupus erythematosus: preliminary observation.Prolactin in human systemic lupus erythematosus.Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus.Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms.High-sensitivity C-reactive protein as an associate of clinical subsets and organ damage in systemic lupus erythematosus.Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers.Anticytokine therapies in systemic lupus erythematosus.Systemic lupus erythematosus, the brain, and anti-NR2 antibodies.Sustained normalization of cerebral blood-flow after iloprost therapy in a patient with neuropsychiatric systemic lupus erythematosus.Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients.Immune function and brain abnormalities in patients with systemic lupus erythematosus without overt neuropsychiatric manifestations.Tumor necrosis factor-alpha and neuropsychiatric lupus erythematosus: relation to single photon emission computed tomography findings.Differential serum cytokine profile in patients with systemic lupus erythematosus and posterior reversible encephalopathy syndrome.Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement.Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosus.Integral Roles for Integrins in γδ T Cell Function.Cerebrospinal fluid levels of a proliferation-inducing ligand (APRIL) are increased in patients with neuropsychiatric systemic lupus erythematosusALS: Cytokine profile in cerebrospinal fluid T‐cell clones
P2860
Q24793525-6E91DB07-528D-4708-8B1B-62A7D60A23CCQ24798439-AF983E60-8836-4915-8B75-D9D1290EB345Q26823647-BBB05BAF-508B-43CC-B2C6-241E1C94E427Q28088753-E4F9CD6B-2FC8-42C0-B89C-6ECD180C55ECQ28268802-903B095C-A9AD-4C0C-94D1-2A6054D4E8CFQ28512739-4BA22616-3282-4126-9176-214330C0524DQ33628713-303D4CEE-5147-4A2F-A862-FD4E53F406E8Q33803103-B42436BC-8E19-43AC-AE33-BEEE4285E01EQ33873329-EB756259-8124-41A0-8D31-C02060EAB6C2Q33941483-8FFB6251-7B6E-4EA6-BD5D-F0C9154BE23FQ34447996-AD7F8C6B-CE98-48BE-AFB8-904B692B48EAQ35550296-17CE3D1D-4934-42EC-8280-768571F31507Q36955326-AE9619A8-4935-4D86-99D6-88103CF22C6CQ37161550-156DE2BD-510E-49C8-A017-6DCBDA64EB81Q37556128-3B47CB01-DE6A-443F-8B1A-141D73A4CF51Q37773296-BD995EC6-86B5-47CC-B2FD-E40B1DE05775Q37930475-0A9B7C3A-F60C-45E6-824E-0D8727361381Q39596714-27BE9D65-A09E-414D-B5DE-8856539229A9Q41945144-6D6C3335-A585-4213-AF6A-89A05FC3B3BFQ45748459-B917B799-B4EC-4172-A3F2-FB11A9432F88Q46467970-0F37EF2B-AE4D-45FB-9FBE-36BCE6B4BB2EQ47899551-CA990A55-8EF4-41A1-AE8F-170D74974E8DQ48172708-34D30F94-65A7-44F4-9E4B-8684770EFF6AQ48329883-985F96F8-1B8D-4C07-AB88-079049674C23Q51730897-F4B2DA47-CF07-4D28-B22E-D4154DDA8FD4Q58190179-FD48C9EB-E253-4D58-8A3A-71069A027514Q58486548-D2CCB237-32FC-40B5-ADE9-2177E7FBE971
P2860
Interleukin-1 and interleukin-6 activities are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T-cell activation markers.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Interleukin-1 and interleukin- ...... ate T-cell activation markers.
@en
type
label
Interleukin-1 and interleukin- ...... ate T-cell activation markers.
@en
prefLabel
Interleukin-1 and interleukin- ...... ate T-cell activation markers.
@en
P2093
P2860
P1433
P1476
Interleukin-1 and interleukin- ...... ate T-cell activation markers.
@en
P2093
D Alarcon-Segovia
D Aleman-Hoey
J Alcocer-Varela
P2860
P304
P356
10.1177/096120339200100209
P577
1992-02-01T00:00:00Z